The FDA approved the first drug in its class that targets moderate to severe acute pain in adults, without being addictive ...
Lenacapavir is a twice-yearly injectable medication designed to be used as pre-exposure prophylaxis (PrEP). The FDA is giving ...
The U.S. Food and Drug Administration said on Tuesday it has approved SpringWorks Therapeutics' drug to treat a type of rare ...
Samsung Bioepis’ biosimilars Ospomyv and Xbryk have been approved to be interchangeable with Prolia/Xgeva treat osteoporosis ...
Just because the FDA approves a drug doesn’t necessarily mean that ... Without Medicare coverage, Leqembi costs $26,500 per year. Also, there are additional costs for brain imaging to ensure ...
GOMEKLI is the first and only medicine approved for both adults and children with NF1-PN –– Approval based on positive data ...
The FDA on Tuesday signed off on SpringWorks Therapeutics’ mirdametinib—now to carry the brand name Gomekli—for the treatment ...
Merilog’s approval comes as the insulin space has over the past year suffered several setbacks, including strong calls for ...
The condition has an estimated worldwide incidence of 43 cases per 1 million population ... Pexidartinib (Turalio) was the only FDA-approved drug treatment, which carries a significant risk ...
HealthDay News — The US Food and Drug Administration (FDA) has approved the first-ever clinical trials testing pig kidney transplants in people with kidney failure, marking a major step forward in ...